Ariad Pharmaceuticals Inc fka ARIA

[vidpok45]

You are right about AF....Just a puppet and not a very bright one at that. LDK378 is completely inferior to 113, and that was obvious even a couple of years ago. What is somewhat surprising is Ponatinib's widespread acceptance despite its toxicity. What has me very excited is its apparent synergy with chemo therapy which could lead to a huge market which will dwarf its current indications. Having Ponatinib, 113, and the mystery molecule and new leadership hopefully soon should get the stock back to where it was pre crash and certainly higher over time if it isnt acquired.....a win/win for everyone here except the shorts.